Literature DB >> 21963404

DNA repair inhibitors: where do we go from here?

Mark R Kelley1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963404      PMCID: PMC3802544          DOI: 10.1016/j.dnarep.2011.09.003

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


× No keyword cloud information.
  9 in total

1.  Beyond PARP inhibitors: agents in pipelines target DNA repair mechanisms.

Authors:  Amy Maxmen
Journal:  J Natl Cancer Inst       Date:  2010-07-28       Impact factor: 13.506

Review 2.  Targeting the DNA double strand breaks repair for cancer therapy.

Authors:  Francesca Gullotta; Elisabetta De Marinis; Paolo Ascenzi; Alessandra di Masi
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.

Authors:  Ruth Plummer
Journal:  Clin Cancer Res       Date:  2010-09-07       Impact factor: 12.531

Review 4.  Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.

Authors:  K Aziz; S Nowsheen; A G Georgakilas
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

5.  Translating cancer research into targeted therapeutics.

Authors:  J S de Bono; Alan Ashworth
Journal:  Nature       Date:  2010-09-30       Impact factor: 49.962

Review 6.  Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer.

Authors:  Rachel Abbotts; Srinivasan Madhusudan
Journal:  Cancer Treat Rev       Date:  2010-01-06       Impact factor: 12.111

Review 7.  Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.

Authors:  Bryan P Rowe; Peter M Glazer
Journal:  Breast Cancer Res       Date:  2010-04-30       Impact factor: 6.466

Review 8.  Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology.

Authors:  Sarah C Shuck; Emily A Short; John J Turchi
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

Review 9.  DNA repair pathways as targets for cancer therapy.

Authors:  Thomas Helleday; Eva Petermann; Cecilia Lundin; Ben Hodgson; Ricky A Sharma
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

  9 in total
  1 in total

Review 1.  Balancing repair and tolerance of DNA damage caused by alkylating agents.

Authors:  Dragony Fu; Jennifer A Calvo; Leona D Samson
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.